REVITALIST LIFESTYLE WLNS - RVLWF STOCK NEWS

Revitalist Lifestyle and Wellness Ltd. announced the appointment of Dr. Denise Hopkins-Chadwick as Senior Vice President of Research. With over 35 years of experience, Dr. Hopkins-Chadwick will lead R&D efforts, focusing on achieving funding goals and securing grants. CEO Kathryn Walker expressed excitement about her joining, emphasizing her impactful background in healthcare research and grant writing, having secured over $50 million in funding. Revitalist continues its mission to enhance well-being through innovative treatments and services across the U.S.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) significantly expanded its operations in 2021, increasing patient treatments by 128% to approximately 5,000. The company reported sales of around $2.2 million, a 110% rise from the previous year. By year-end, it grew to seven clinics across four states, planning further expansions. Notably, it secured Medicare coverage and raised over $11 million in capital. Revitalist also ventured into the metaverse with a 60% stake in Revitaland Meta Tech Inc. CEO Kathryn Walker celebrated the company's achievements, including her recognition as Entrepreneur of the Year.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) is enhancing its capabilities in the psychedelic field through advanced training in Advanced Cardiovascular Life Support (ACLS). This initiative aims to improve safety and care at its clinics, which are expanding across the U.S. The company reports that ACLS-certified providers significantly reduce care delivery errors, enhancing the efficacy of treatment. CEO Kathryn Walker emphasizes the company's commitment to advancing psychedelic care and establishing a strong safety culture in this emerging industry.

Revitalist Lifestyle and Wellness Ltd. (OTC: RVLWF) has finalized an asset purchase agreement to acquire a Ketamine clinic in Jacksonville, Florida, adding its ninth location. The acquisition, valued at $100,000, includes $60,000 in cash and $40,000 in common shares. This clinic, operational since 2017 and managed by Dr. Nicholas Kalynych, aims to enhance service offerings and patient access. Revitalist now has clinics in six states, reinforcing its growth strategy. The transition is expected to fully integrate under the Revitalist brand by February 1, 2022.

Revitalist Lifestyle and Wellness Ltd. has opened its eighth psychedelic assisted psychotherapy clinic near Washington, D.C., located at 4833 Rugby Ave, Bethesda, MD. The clinic will offer a range of treatments including ketamine infusions, Spravato, and telemedicine therapy. With 10 treatment rooms, it aims to provide over 10,400 infusions annually. The new facility emphasizes care for military veterans, with experienced nurse anesthetists leading the clinic. The U.S. military has invested $26.9M in psychedelic research through DARPA, highlighting the growing acceptance of these treatments.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) announces that CEO Kathryn Walker will present at the H.C. Wainwright Bioconnect Conference from January 10-13, 2022. The virtual presentation will be available on-demand starting January 10 at 7:00 a.m. ET. Additionally, the company has granted 430,000 stock options and 130,000 restricted share units to employees, with options exercisable at $0.20 per share. Revitalist is committed to improving individuals' well-being through comprehensive healthcare and has multiple clinics across the U.S.

Revitalist Lifestyle and Wellness Ltd. has officially been notified by OTC Markets of its up-listing from Pink Sheet to the OTCQB tier, effective December 20, 2021. This transition aims to enhance trading quality and transparency for its investors. The OTCQB tier signifies a higher level of compliance, requiring companies to be current in financial reporting and pass various eligibility tests. CEO Kathryn Walker expressed confidence that this strategic move will deliver increased value to shareholders, reinforcing the company's commitment to transparency.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) has signed nine definitive agreements with Certified Registered Nurse Anesthetists (CRNAs) across the United States, expanding its clinic pipeline to nineteen locations in eleven states. This growth includes an estimated 242 treatment rooms, following the opening of seven clinics in 2021. CEO Kathryn Walker highlighted strong support from CRNAs in this expansion effort, emphasizing the company's commitment to enhancing well-being through innovative treatments.

Revitalist Lifestyle and Wellness Ltd. has signed a lease for its ninth psychedelic assisted psychotherapy clinic in Jacksonville, Florida, expanding its capacity to 60,657 square feet and 121 treatment rooms across multiple states. The 6,865-square-foot clinic will feature 12 infusion rooms and is expected to open by December 31, 2021. Revitalist aims to address the mental health crisis, with a reported 9.5% of American adults facing depressive illnesses annually. This addition reflects Revitalist's ongoing commitment to providing innovative mental health treatments.